Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Other Non-Current Assets (2016 - 2025)

Sanofi's Other Non-Current Assets history spans 6 years, with the latest figure at $5.1 billion for Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed N/A year-over-year to $5.1 billion; the TTM value through Dec 2025 reached $5.1 billion, changed N/A, while the annual FY2025 figure was $4.9 billion, N/A changed from the prior year.
  • Other Non-Current Assets for Q4 2025 was $5.1 billion at Sanofi, up from $3.5 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $5.1 billion in Q4 2025 and bottomed at $3.5 billion in Q4 2023.